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Abstract
Background—In regions where prenatal screening for anencephaly and spina bifida is 
widespread, many cases of these defects are prenatally diagnosed. The purpose of this study was 
to estimate the frequency of termination of pregnancy (TOP) following prenatal diagnosis of 
anencephaly or spina bifida and to investigate factors associated with TOP that might lead to 
selection bias in epidemiologic studies.
Methods—We included articles indexed in Medline and Embase between 1990 and May 2012 
reporting the frequency of TOP following prenatal diagnosis of anencephaly or spina bifida with 
English-language abstracts, ≥20 prenatally diagnosed cases, and at least half of the study years in 
1990 or later. We summarized the frequency of TOP across studies using random-effects meta-
analysis and stratified results by fetal and study characteristics.
Results—Among the 17 studies identified, 9 included anencephaly and 15 included spina bifida. 
Nine were from Europe, 6 were from North America, and 1 each was from South America and 
Asia. The overall frequency of TOP following prenatal diagnosis was 83% for anencephaly 
(range: 59–100%) and 63% for spina bifida (range: 31–97%). There were insufficient data to 
stratify the results for anencephaly; TOP for spina bifida was more common when the prenatal 
diagnosis occurred <24 weeks gestation, with defects of greater severity, and in Europe versus 
North America.
Conclusions—Because underascertainment of birth defects might be more likely when the 
pregnancy ends in TOP and TOP is associated with fetal characteristics, selection bias is possible 
in epidemiologic studies of anencephaly or spina bifida.
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Neural tube defects (NTDs) are birth defects caused by failure of the neural tube to close 
completely, resulting in incomplete formation of the brain or spinal cord (Botto et al., 1999; 
Mitchell et al., 2004). The two most common types of NTDs are anencephaly, characterized 
by absence of much of the skull and brain, and spina bifida, a herniation of neural tissue 
through an incompletely formed spine (Botto et al., 1999). Anencephaly is a lethal condition 
and liveborn infants typically survive less than one day (Jaquier et al., 2006; Obeidi et al., 
2010). The severity of spina bifida is more variable. Complications of spina bifida can lead 
to death; however, this is not the most common outcome, with over 90% of liveborn infants 
with spina bifida in the United States surviving the first year of life with varying levels of 
sensory loss and paralysis (Bol et al., 2006; Doherty and Shurtleff, 2006).
Screening for elevated maternal serum alpha-fetoprotein levels in the second trimester of 
pregnancy can identify over two-thirds of fetuses with open neural tube defects (defects that 
are not covered by skin), including almost all fetuses with anencephaly (Cameron and 
Moran, 2009; Driscoll et al., 2009). The rapid increase in use of second and third trimester 
ultrasonography since the 1970s has led to prenatal ultrasounds becoming a common and 
effective method for prenatal screening for and detection of NTDs and other birth defects 
(Peller et al., 2004). Given the often severe nature of NTDs, termination of pregnancy (TOP) 
is common following prenatal diagnosis if the diagnosis is made early enough for this to be 
an available option (Mansfield et al., 1999).
The increasing frequency of prenatal diagnosis and TOP has important implications for the 
interpretation of results from epidemiologic studies of birth defects such as NTDs, for which 
both prenatal diagnosis and TOP are relatively common. Not all fetuses with NTDs are able 
to be included in epidemiologic studies. Cases from pregnancies ending in TOP are more 
difficult to ascertain than those ending in live birth and typically require inclusion of 
additional case ascertainment sources. Descriptive studies underestimate the number of 
pregnancies with recognized NTDs when only live births are included or some proportion of 
affected pregnancies resulting in TOPs is missed (Roberts et al., 1995; Bower et al., 2001; 
Cragan and Gilboa, 2009). In etiologic studies, exclusion or incomplete ascertainment of 
NTDs among TOPs can lead to selection bias when the exposure of interest is associated 
with likelihood of TOP (Cragan and Khoury, 2000). Clinical studies of long-term outcomes 
following infants from birth might not be useful for counseling parents with prenatally 
diagnosed fetuses about prognosis if liveborn infants represent only a small, selected subset 
of all affected pregnancies.
Quantifying the frequency of TOP and factors associated with TOP is important for 
understanding how underascertainment of cases might affect study results. A systematic 
review of studies published between 1987 and 1995 estimated that 84% and 64% of 
pregnancies known to be affected with anencephaly and spina bifida, respectively, ended in 
TOP (Mansfield et al., 1999). Since that review was published, no further summary of the 
frequency of TOP has been performed to determine if these estimates still accurately reflect 
the present-day situation. The purpose of the present analysis is to estimate the proportion of 
pregnancies ending in TOP following prenatal diagnosis of anencephaly or spina bifida 
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during a time period when ultrasonography was widely used for prenatal diagnosis of NTDs 
and to investigate factors associated with TOP that could contribute to selection bias in 
epidemiologic studies of these defects.
METHODS
Search Strategy
We included epidemiologic studies indexed in Medline and Embase from 1990 through May 
2012 that reported both the number of cases of anencephaly or spina bifida prenatally 
diagnosed in a specific time period and the number of these cases in which the pregnancy 
outcome was TOP. The search strategy included search terms and synonyms for “neural 
tube defect”, “anencephaly”, “spina bifida”, “prenatal diagnosis”, and “pregnancy 
termination” (Appendix). We identified additional studies by searching reference lists of 
included articles and by using Google Scholar to search for more recently published articles 
citing the included studies. Information abstracted from each article included location and 
dates of participant recruitment, number of prenatally diagnosed cases of anencephaly or 
spina bifida, the number of these cases with TOP as the pregnancy outcome, and fetal and 
study characteristics such as defect type and the country where the study was conducted 
(described in further detail below).
Inclusion and Exclusion Criteria
Two types of studies were eligible for inclusion: studies following a prospective or 
retrospective cohort of prenatally diagnosed fetuses to determine outcome of pregnancy and 
studies using birth defects surveillance or registries that ascertain prenatally diagnosed cases 
and pregnancies ending in TOP (although ascertainment might not be complete). Additional 
inclusion criteria were: an English-language abstract, pregnancy outcome known for at least 
20 prenatally diagnosed cases of anencephaly or of spina bifida, and at least half the study 
years in 1990 or later. We restricted our analysis to studies of at least 20 prenatally 
diagnosed cases to ensure the estimates were fairly stable. The restriction to studies mostly 
conducted in 1990 or later was made because after this time fetal ultrasound was in 
widespread use in most countries monitoring neural tube defects and the decision to 
continue or end an affected pregnancy would have likely involved not only serum screen 
results but also ultrasound confirmation of the specific defect.
We excluded studies that analyzed only fetuses with both NTDs and other specific non-NTD 
diagnoses (e.g., studies of fetuses with both NTDs and chromosomal abnormalities) or 
specific indications on ultrasound (e.g. studies of fetuses with both NTDs and increased 
nuchal translucency). We also excluded studies conducted exclusively in non-singletons. 
When two studies included information from overlapping populations, we included the most 
recent study or the study with the largest catchment area (e.g., a national study would be 
chosen over a regional study). Studies were also excluded if they were conducted in a 
location where no TOP was reported because it was not legally permitted at any gestational 
age.
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In each study, we calculated the frequency of TOP as the number of pregnancies ending in 
TOP among those in which a prenatal diagnosis was made and pregnancy outcome was 
known. We used random-effects meta-analysis of proportions to calculate the combined 
frequency of TOP and 95% confidence interval (CI) across studies. The I2 statistic and 95% 
uncertainty interval (UI) were used to quantify between-study heterogeneity. I2 ranges from 
0 to 100% and is an estimate of the proportion of variability that is attributable to between-
study variability as opposed to chance. Values of 25%, 50%, and 75% have been suggested 
as rough indications of low, moderate, and high proportions of between-study heterogeneity 
(Higgins et al., 2003). Analyses were conducted using the ‘meta’ package in R (www.r-
project.org).
In some studies, pregnancies were lost to follow-up and the outcome of pregnancy was 
unknown. When this occurred, we restricted the analysis to the subset of pregnancies with 
known outcomes to make these studies comparable to studies which reported no pregnancies 
lost to follow-up; it was often not possible to determine if a study truly had no pregnancies 
lost to follow-up or if these pregnancies were excluded prior to analysis. If this restriction 
decreased the number of cases in the study to less than 20, the article was considered to be 
ineligible for inclusion.
If fetuses undergoing surgery for in utero spina bifida repair had been excluded from the 
original study, we added them back into our analysis and categorized them as pregnancies 
not ending in TOP.
To investigate factors potentially associated with TOP, we categorized studies according to 
study design (cohort vs. surveillance or registry), case type (all cases vs. isolated defects), 
defect type (open vs. closed, for spina bifida only), geographic region (Europe vs. North 
America), and gestational age at prenatal diagnosis (<24 weeks vs. ≥24 weeks); we 
identified this set of variables after reading the included articles and determining what 
information was available. If results were reported for more than one stratum (e.g., results 
for open and closed defects presented separately within the same article), the article was 
included once in each category. For these stratified analyses, we did not restrict our analyses 
to subgroups with 20 or more prenatally diagnosed cases. We compared meta-analysis 
results across strata using a two-sided Z-test for proportions.
RESULTS
We identified 15 articles meeting inclusion criteria using the search strategy (Harmon et al., 
1995; Forrester and Merz, 2000; Waller et al., 2000; Olde Scholtenhuis et al., 2003; Biggio 
et al., 2004; Garne et al., 2005; Ghi et al., 2006; Nikkila et al., 2006; Tairou et al., 2006; 
D’Addario et al., 2008; Poretti et al., 2008; Aguilera et al., 2009; Amari et al., 2010; Lu et 
al., 2011; Machado et al., 2012). One additional article was found using Google Scholar 
(this article had cited one of the articles identified using the search strategy) (Adama van 
Scheltema et al., 2003) and one article was known to the authors and included (Shulman et 
al., 1994). Of these 17 included articles, 9 reported information on anencephaly and 15 on 
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spina bifida. Nine articles were from Europe, 6 were from North America, 1 was from South 
America, and 1 was from Asia.
Frequency of TOP in Included Studies
The overall frequency of TOP following prenatal diagnosis in the 9 studies of anencephaly 
was 83% (95% CI, 70–93%) by random-effects meta-analysis and ranged from 59% to 
100% in individual studies (Table 1). In the 15 studies of spina bifida, the overall frequency 
of TOP by random-effects meta-analysis was 63% (95% CI, 51–74%) and estimates from 
individual studies ranged from 31% to 97%. There was substantial between-study 
heterogeneity in each meta-analysis (anencephaly I2 = 95%, spina bifida I2 = 95%).
Factors Investigated in Association With Frequency of TOP
There were few studies of anencephaly available to investigate factors associated with 
frequency of TOP between studies; therefore, only results for spina bifida are shown (Table 
2). No study provided data to evaluate associations between maternal sociodemographic 
characteristics and TOP after prenatal diagnosis of spina bifida.
Geographic region—In both North America and Europe, the frequency of TOP following 
prenatal diagnosis of spina bifida was variable. Estimates ranged from 31% to 82% in North 
America and from 41% to 89% in Europe. Overall, TOP following prenatal diagnosis was 
more common in Europe (66%) than North America (50%).
Study design—Of the 15 studies, 5 used data from birth defect surveillance or registries 
and the remainder followed a cohort of prenatally diagnosed fetuses for pregnancy outcome. 
All cohort studies were hospital-based. and used records of prenatal diagnoses as the source 
of data. Of the 5 surveillance or registry studies, 2 had hospital-based case ascertainment 
and the rest had multiple sources of hospital- and non-hospital-based ascertainment. 
Estimates from studies using surveillance or registries were similar to those from cohort 
studies (64% vs. 62%); however, results from the surveillance and registry studies stratum 
were heavily influenced by two studies with large sample size (n >100) and high prevalence 
of TOP (>75%) (Garne et al., 2005; Lu et al., 2011).
Case type—Five studies presented analyses restricted to fetuses with isolated spina bifida 
and the remainder included all types of cases. TOP was more common in studies including 
all types of cases than those restricted to fetuses with isolated defects (66% vs. 56%).
Defect type—Two studies presented results for closed spina bifida and five for open spina 
bifida. In the two studies of closed spina bifida, the frequency of TOP was 22% and 50% 
(combined frequency: 33%), but both estimates were based on small subgroup analyses 
within each study and included fewer than 10 prenatally diagnosed fetuses. For open spina 
bifida, the estimates ranged from 36% to 91% (combined frequency: 60%).
Gestational age at prenatal diagnosis—Four studies (all from Europe) reported 
frequency of TOP stratified by gestational age at prenatal diagnosis (<24 versus ≥24 
gestational weeks). TOP was more common when prenatal diagnosis was made <24 weeks 
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rather than later (86% vs. 27%). Gestational age at prenatal diagnosis appeared to be 
responsible for some of the between-study variability (Table 3). For example, the overall 
frequency of TOP was lower in the Netherlands (49%) than other European countries (78%), 
but once restricted to prenatal diagnoses made <24 weeks, the Netherlands and other 
European countries had similar estimates (92% vs. 91%). Nevertheless, between-study 
heterogeneity remained high after stratifying on gestational age (<24 weeks: I2 = 62%, ≥24 
weeks: I2 = 78%).
DISCUSSION
Among the studies identified in this review, 83% of pregnancies known to be affected with 
anencephaly and 63% of those known to be affected with spina bifida ended in TOP. 
However, no study presumably had 100% sensitivity for ascertaining NTDs and sensitivity 
likely varied between included studies. Because epidemiologic studies and surveillance 
programs are more likely to underascertain pregnancies prenatally diagnosed and ending in 
TOP than those ending in live births (Cragan et al., 1995), these are likely to be 
underestimates of the prevalence of TOP.
These estimates are similar to those from a previous systematic review of the frequency of 
TOP published over a decade ago: 84% (95% CI, 82–86%) for anencephaly and 64% (95% 
CI, 61–67%) for spina bifida (Mansfield et al., 1999). Although the similarity between 
estimates in the present and previous reviews suggests that the likelihood of TOP following 
prenatal diagnosis of anencephaly or spina bifida has not appreciably changed over time, the 
overlap in the study years and differences in the inclusion and exclusion criteria between 
reviews make any direct comparison of results difficult. A study analyzing time trends 
within a single population would be needed to confirm if there have been changes in the 
proportion of pregnancies ending in termination over time.
With a substantial proportion of pregnancies ending in TOP following prenatal diagnosis, 
investigators should be aware that epidemiologic studies conducted only among live births 
include a highly selected sample of the total population of fetuses with NTDs. Previous 
studies have reported that maternal characteristics such as education, age, and race/ethnicity 
are associated with the outcome of NTD-affected pregnancies (Velie and Shaw, 1996; Parks 
et al., 2011); however, these studies have not separated the effects of these characteristics on 
the decision to terminate a pregnancy following prenatal diagnosis from their effects on 
access to or uptake of prenatal diagnosis. Two studies included in this review investigated 
maternal characteristics associated with TOP following prenatal diagnosis. One reported no 
difference in maternal age, gravidity, parity, or history of spontaneous abortions between 
pregnancies ending in TOP compared to other pregnancy outcomes following prenatal 
diagnosis of anencephaly (Machado et al., 2012). The second did not present results 
separately for each NTD type (anencephaly, spina bifida, and encephalocele) but found that 
TOP following prenatal diagnosis of NTDs was more common in older than younger 
mothers, in Asian compared to white mothers, and in certain areas of their study catchment 
area in Hawaii (Forrester and Merz, 2000). Because these characteristics are associated with 
TOP and therefore inclusion in the study, selection bias is possible in studies investigating 
these factors in relation to NTD etiology (Cragan and Khoury, 2000). Further studies will be 
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needed to evaluate whether these and other maternal and fetal characteristics are associated 
with TOP following prenatal diagnosis for different NTD subtypes.
Regional differences in average gestational age at prenatal diagnosis are a possible 
explanation for some of the observed between-study variability in frequency of TOP. 
Greater frequency of TOP is expected at earlier gestational ages because many regions have 
laws restricting the gestational ages at which TOP may be performed. These results suggest 
the importance of considering characteristics that delay prenatal diagnosis as potential 
sources of selection bias. As an example, ultrasound visualization of the fetal anatomy and 
prenatal diagnosis of birth defects is more difficult in obese mothers than normal weight 
mothers (Hendler et al., 2004; Dashe et al., 2009). If the ultrasound examination must be 
repeated later in pregnancy to complete the fetal anatomic examination or if an accurate 
diagnosis cannot be made, obese mothers might have on average a later gestational age at 
prenatal diagnosis than non-obese mothers and therefore be less likely to be able to consider 
a TOP (Hendler et al., 2004; Phatak and Ramsay, 2010). As a result, non-obese mothers 
might be more likely to have a TOP than obese mothers and cases of NTDs among non-
obese mothers might be missed, creating a potentially spurious association between 
prepregnancy obesity and NTDs.
Severity of the defect is another important consideration for continuing or terminating a 
pregnancy following prenatal diagnosis (Evans et al., 1996; Peller et al., 2004; Shaffer et al., 
2006). Pregnancies complicated by a severe NTD or one accompanied by multiple major 
malformations might be more likely to end in TOP than an isolated NTD or a less severe 
case. Severity of the defect is more relevant for spina bifida than anencephaly because the 
latter is uniformly lethal. In our review there was little information on the effect of severity 
of spina bifida on likelihood of TOP, but the results suggested a higher frequency of TOP 
for fetuses with open defects compared to those with closed defects. This point is important 
when results from studies reporting clinical outcomes such as shunting or mobility 
impairment are used to counsel families with a prenatally diagnosed fetus on long-term 
prognosis. Consideration should be given to the possibility that the fetuses most likely to be 
liveborn and to have follow-up information available are those with the least severe defects; 
thus, results from studies based on liveborn infants might not be generalizable to all 
prenatally diagnosed fetuses.
Incomplete ascertainment of cases of anencephaly or spina bifida among pregnancies ending 
in TOP also pose problems for evaluating population-based interventions for the prevention 
of these defects. For example, using data from surveillance to evaluate the success of folic 
acid fortification programs is difficult because of the high frequency of prenatal diagnosis 
and TOP and the difficulty in separating the effects of the intervention from changes in 
prenatal diagnosis and TOP over time (Besser et al., 2007); in this situation, alternate 
strategies such as bio-monitoring might be warranted (Oakley et al., 2008).
One limitation of this study was the inability of our search strategy to identify all relevant 
articles. Restricting the search databases to Medline and Embase likely resulted in missed 
articles in languages other than English and articles from journals not indexed by these 
databases, particularly those outside North America and Europe. Because reporting the 
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proportion of pregnancies with prenatal diagnosis ending in TOP is not a common study 
objective, this information is often presented in the text and not the abstract. There might be 
other articles reporting the frequency of TOP following prenatal diagnosis not captured by a 
search strategy that exclusively searches abstracts; this could affect our conclusions if study 
results systematically differ between studies identified and not identified by our search 
strategy. A second limitation of our analysis was the exclusion of prenatally diagnosed 
fetuses with unknown pregnancy outcomes by us or by authors of the included studies. This 
exclusion would likely produce underestimates of the frequency of TOP if pregnancies with 
unknown outcomes might be more likely to represent TOP than the more easily ascertained 
live births. Third, estimates from each study were variable. Although we presented a 
summary frequency of TOP to capture the overall state of the available literature, the 
frequency of TOP likely varies by region. Given the evidence available in the literature, it 
was not possible to determine if this variability was due to differences in attitudes toward 
TOP, timing of prenatal diagnosis, laws restricting TOP, case ascertainment procedures, or 
other reasons.
Our results suggest, in accordance with previous studies, that TOP is the most common 
outcome of pregnancy following prenatal diagnosis of anencephaly and spina bifida, 
particularly when the prenatal diagnosis is made prior to 24 weeks of gestation. The 
relatively small proportion of fetuses with NTDs presenting as live births will present 
challenges to investigators conducting studies in which not all NTD-affected pregnancies 
among TOPs are included. A better understanding of factors associated with TOP following 
prenatal diagnosis of anencephaly or spina bifida will provide much needed information on 
the potential for selection bias in etiologic studies and generalizability in studies of the 
prognosis of prenatally diagnosed fetuses.
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